139 related articles for article (PubMed ID: 38689257)
41. Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda.
Hansen KS; Pedrazzoli D; Mbonye A; Clarke S; Cundill B; Magnussen P; Yeung S
Health Policy Plan; 2013 Mar; 28(2):185-96. PubMed ID: 22589226
[TBL] [Abstract][Full Text] [Related]
42. The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys.
Edwards HM; Sarwar R; Mahmud P; Emmanuel S; Maxwell K; Tibenderana JK
Malar J; 2022 Feb; 21(1):42. PubMed ID: 35151332
[TBL] [Abstract][Full Text] [Related]
43. Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.
Prudhomme O'Meara W; Menya D; Laktabai J; Platt A; Saran I; Maffioli E; Kipkoech J; Mohanan M; Turner EL
PLoS Med; 2018 Jul; 15(7):e1002607. PubMed ID: 30016316
[TBL] [Abstract][Full Text] [Related]
44. Fever case management at private health facilities and private pharmacies on the Kenyan coast: analysis of data from two rounds of client exit interviews and mystery client visits.
Poyer S; Musuva A; Njoki N; Okara R; Cutherell A; Sievers D; Lussiana C; Memusi D; Kiptui R; Ejersa W; Dolan S; Charman N
Malar J; 2018 Mar; 17(1):112. PubMed ID: 29534750
[TBL] [Abstract][Full Text] [Related]
45. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H
BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199
[TBL] [Abstract][Full Text] [Related]
46. Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.
Amuasi JH; Diap G; Nguah SB; Karikari P; Boakye I; Jambai A; Lahai WK; Louie KS; Kiechel JR
PLoS One; 2012; 7(10):e47733. PubMed ID: 23133522
[TBL] [Abstract][Full Text] [Related]
47. Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies.
; Phok S; Lek D
Malar J; 2017 Apr; 16(1):171. PubMed ID: 28438204
[TBL] [Abstract][Full Text] [Related]
48. Insights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regions.
Adjei AA; Winch P; Laar A; Sullivan DJ; Sakyi KS; Stephens JK; Adjei GO; Boateng IA; Aubyn VN; Kubio C; Tuakli J; Vanotoo L; Bortei BB; Amo-Addae M; Sorvor F; Coleman N; Dalglish S; Owusu R; Gebreyesus T; Essuman E; Greene R; Ankomah E; Houston K; Bart-Plange C; Salamat S; Addison EA; Quakyi IA
Malar J; 2016 May; 15(1):263. PubMed ID: 27160685
[TBL] [Abstract][Full Text] [Related]
49. Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana.
Freeman A; Kwarteng A; Febir LG; Amenga-Etego S; Owusu-Agyei S; Asante KP
J Pharm Policy Pract; 2017; 10():15. PubMed ID: 28465829
[TBL] [Abstract][Full Text] [Related]
50. Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
Ocan M; Nakalembe L; Otike C; Omali D; Buzibye A; Nsobya S
Malar J; 2023 May; 22(1):165. PubMed ID: 37237283
[TBL] [Abstract][Full Text] [Related]
51. Anti-malarial market and policy surveys in sub-Saharan Africa.
Diap G; Amuasi J; Boakye I; Sevcsik AM; Pecoul B
Malar J; 2010 Apr; 9 Suppl 1(Suppl 3):S1. PubMed ID: 20423536
[TBL] [Abstract][Full Text] [Related]
52. The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial.
Kangwana BP; Kedenge SV; Noor AM; Alegana VA; Nyandigisi AJ; Pandit J; Fegan GW; Todd JE; Snow RW; Goodman CA
Malar J; 2013 Mar; 12():81. PubMed ID: 23452547
[TBL] [Abstract][Full Text] [Related]
53. Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi.
Amuasi JH; Diap G; Blay-Nguah S; Boakye I; Karikari PE; Dismas B; Karenzo J; Nsabiyumva L; Louie KS; Kiechel JR
Malar J; 2011 Feb; 10():34. PubMed ID: 21310057
[TBL] [Abstract][Full Text] [Related]
54. Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016.
; Thein ST; Khin HSS; Thi A
Malar J; 2017 Apr; 16(1):129. PubMed ID: 28438197
[TBL] [Abstract][Full Text] [Related]
55. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.
Tivura M; Asante I; van Wyk A; Gyaase S; Malik N; Mahama E; Hostetler DM; Fernandez FM; Asante KP; Kaur H; Owusu-Agyei S
BMC Pharmacol Toxicol; 2016 Oct; 17(1):48. PubMed ID: 27788677
[TBL] [Abstract][Full Text] [Related]
56. Investigating unlicensed retail drug vendors' preparedness and knowledge about malaria: An exploratory study in rural Uganda.
Liow E; Kassam R; Sekiwunga R
Acta Trop; 2017 Oct; 174():9-18. PubMed ID: 28606818
[TBL] [Abstract][Full Text] [Related]
57. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S; Hetzel MW; Goodman C; Dillip A; Liana J; Mshinda H; Lengeler C
Malar J; 2010 Jun; 9():164. PubMed ID: 20550654
[TBL] [Abstract][Full Text] [Related]
58. Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda.
Mbonye AK; Lal S; Cundill B; Hansen KS; Clarke S; Magnussen P
Malar J; 2013 Apr; 12():131. PubMed ID: 23587179
[TBL] [Abstract][Full Text] [Related]
59. Private sector antimalarial sales a decade after "test and treat": A cross-sectional study of drug shop clients in rural Uganda.
Shelus V; Mumbere N; Mulogo EM; Barrington C; Baguma E; Muhindo R; Herrington JE; Emch M; Maman S; Boyce RM
Front Public Health; 2023; 11():1140405. PubMed ID: 37056663
[TBL] [Abstract][Full Text] [Related]
60. Extent of inappropriate prescription of artemisinin and anti-malarial injections to febrile outpatients, a cross-sectional analytic survey in the Greater Accra region, Ghana.
Bonful HA; Awua AK; Adjuik M; Tsekpetse D; Adanu RMK; Nortey PA; Ankomah A; Koram KA
Malar J; 2019 Sep; 18(1):331. PubMed ID: 31558149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
